India’s Serum Institute and Novavax Inc whose COVID-19 vaccine candidate showed promising results in the initial clinical trials have signed an exclusive supply and license agreement for the production of the COVID-19 vaccine in India.
Apart from the exclusive production and development license of the vaccine in India, Serum institute has also struck a deal to get non-exclusive rights to produce the drug in other developing nations as well, reported Financial Express (FE) quoting the news agency Reuters.
The deal, signed on July 30, will last till the time COVID-19 pandemic gets over, the report added.
More details about the vaccine and its trial:
New Delhi: If latest satellite pictures are an indication, China could be building a road in…
Bhubaneswar: Well-known technocrat Hara Prasanna Mishra passed away in Bhubaneswar on April 21. He was…
Bhubaneswar: Police have arrested three persons for allegedly producing fake bail bond in a court…
Bhubaneswar: Siksha ‘O’ Anusandhan (SOA) Deemed to be University on Thursday signed a Memorandum of…
Bhubaneswar: Even as entire Odisha came under severe heatwave with 22 places recording 42 degree…
Bhubaneswar: Another feather was added to Dr Achyuta Samanta’s cap on Wednesday when he was…
Bhubaneswar: After projecting themselves as the sole custodian of Odisha's culture, history and aspirations, the…
London: Former Zimbabwean Test cricketer Guy Whittall had a close shave recently after being attacked by…